Clinical stage therapeutics company sets terms for $53 million IPO

Lyra Therapeutics Inc. set terms for its planned initial public offering on Monday, saying it will offer 3.5 million shares priced at…

  Read more »

3 Recent IPOs to Add to Your Watchlist

Savvy investors know that keeping a watchlist is one of the most valuable strategies that can be employed, since it can be extremely frustrating — and costly — when investors

  Read more »

Will Last Week’s Biotech IPO Outperform in a Recession?

A cancer drug developer successfully raised $120 million in its IPO on Friday, and the stock posted a splashy opening-day gain of 61%. Here are a few reasons why…

  Read more »

Is 2019 IPO Zoom Video Communications (ZM) Stock S&P 500-Bound?

Zoom Video Communications (NASDAQ:ZM) has been one of the most successful stocks of 2020. The video conferencing specialist has taken advantage of a unique set of circumstances that have lifted its

  Read more »

DraftKings goes public today despite lack of live sports to bet on

Sports daily fantasy and betting website DraftKings will debut as a publicly traded company Friday despite a near-complete shutdown of athletic competition across the globe due to the coronavirus pandemic…

  Read more »

These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?

An initial public offering (IPO) has a special allure: It draws in speculative investors eager to see stocks soar in the initial days of trading. In weak markets, only the

  Read more »

Virgin Galactic dealmaker defies IPO lull with $720 million blank-check deal

Virgin Galactic Holdings Inc (SPCE.N) Chairman Chamath Palihapitiya on Tuesday raised $720 million for a new blank-check company, 20% more than its original target, after the coronavirus crisis upended plans

  Read more »

Biotech Listings Help Prop Up Anemic U.S. IPO Market

Biotechnology offerings are one of the few bright spots in an otherwise dreary market for initial public offerings and could hold steady for the rest of the year, even as

  Read more »

If You Invested $10,000 in Gilead Sciences’ IPO, This Is How Much Money You’d Have Now

A lot of people are talking about¬†Gilead Sciences (GILD) these days. The big biotech’s antiviral drug remdesivir has made headlines because of its promise in treating novel coronavirus disease COVID-19.

  Read more »

1 Recent IPO to Add to Your Watch List

The coronavirus pandemic has made it clear that, despite all of the cutting-edge technologies in healthcare, there’s still much that scientists don’t know about how the human immune system works…

  Read more »